Alberta government to learn from ruling on Ontario bike lane law: minister
Devin Dreeshen says Alberta will be watching the case with interest, especially since Ontario's government plans to appeal the ruling.
Dreeshen says being the second province to go down the same path is helpful, as it gives Alberta the opportunity to analyze the "good and bad" parts of Ontario's legislation.
The minister met earlier in the day with Calgary Mayor Jyoti Gondek to discuss bike infrastructure in her city.
Dreeshen and Gondek say the meeting was collaborative and they agreed bike lanes are temporary.
Gondek says Calgary is open to making changes if a bike lane creates congestion issues.
This report by The Canadian Press was first published July 30, 2025.
The Canadian Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
US to initially impose 'small tariff' on pharma imports, Trump says
By Patrick Wingrove and Andrea Shalal WASHINGTON (Reuters) -President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical imports before hiking it to 150% within 18 months and eventually to 250% in an effort to boost domestic production. "In one year, one and a half years maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country," Trump told CNBC in an interview. He did not specify the initial tariff rate on pharmaceuticals. Trump said earlier this month that pharmaceutical tariffs could reach as high as 200%. Trump also said he plans to announce tariffs on semiconductors and chips in the "next week or so," but gave no further details. The United States has been conducting a national security review of the pharmaceutical sector, and the industry has been preparing for possible sector-specific tariffs. The administration has not announced when the results of that probe will be released. A framework agreement between the United States and the EU sets out that tariffs on pharmaceuticals and semiconductors are currently zero, but if the United States raises tariffs following its import investigation, they will be capped at 15%.
Skift
12 minutes ago
- Skift
'Never Seen a Drop Like This:' U.S. Politics Drive Meeting Attendees Away
The sharp decline in global attendance at a recent international medical congress is more than a one-off, it's a red flag. As political rhetoric escalates, the U.S. is becoming a less viable destination for truly international meetings. Attendance at the International Society on Thrombosis and Haemostasis Congress in Washington, D.C. this June fell well below expectations, a warning to organizers who rely on the U.S. as a global meetings hub. The group expected 6,000 attendees, but just 4,500 showed up. Canadian participation alone plummeted 55% from the 2023 meeting in Montreal, while attendance from the UK, France, and the Netherlands was down nearly 30%. An additional 500 U.S.-based registrants was not enough to compensate for the decline in international participation. 'We have never seen a drop like this,' said Thomas Reiser, executive director of ISTH. 'Our numbers are very low for a truly international congress.' In total, 55% of attendees came from outside the U.S., a drop from the typical 75%. U.S. Political Climate a Deterrent A mix of factors drove the decline, said Reiser. The biggest was a growing discomfort with the U.S. political environment. In addition, some European countries as well as Canada have issued advisories for travelers to the U.S., and some international scientific organizations have recommended against sending researchers to the U.S., said Resier. 'U.S. politics, more so than geopolitics, although the Middle East conflict also played a role, particularly with the U.S.'s greater involvement in the weeks before the congress had an impact. We received information from quite a few members in particular, Canada, the UK, and Western Europe, typically some of the strongest membership and registration countries, that either they themselves did not feel comfortable attending or their institutions had travel advisories, including recommendations not to go to the U.S.,' said Reiser. Although actual travel and border entry went smoothly for those who attended, perception damage had already been done. 'Media reports about possible questioning, detentions, and refusal of entry into the U.S. did not help,' he said. Revenue Takes a Hit The consequences are not just a decline in attendees. 'We heard from several participants, exhibitors, and sponsors that they would have expected higher numbers overall,' said Reiser. 'With an overall reduction in numbers of an estimated 20 to 25%, this of course has a significant financial impact on the meeting and the society. This may also have a bit of an impact on future congresses, if sponsors and exhibitors believe our registration numbers are closer to 4,500 than 6,000.' Next year's meeting will be in Paris. The 2027 meeting, which should be in North America due to event rotation, is under review. 'We're in the midst of considering whether the U.S. is the right destination for an international meeting like ours,' Reiser said. 'It's an unfortunate situation. The way the U.S. is perceived is having a real impact in the scientific space.'
New York Times
12 minutes ago
- New York Times
Rupert Murdoch and Trump Agree to Postpone Deposition
Rupert Murdoch and President Trump have agreed to postpone Mr. Murdoch's deposition in the president's lawsuit against The Wall Street Journal. Mr. Trump had argued that Mr. Murdoch, who is 94, should be deposed within 15 days because of his age and health. According to court documents filed on Monday, Mr. Murdoch and Mr. Trump have reached a deal to pause that request until after The Journal's motion to dismiss the case is heard by the judge. Mr. Trump sued The Journal last month after the newspaper published an article about a lewd birthday note that the publication said Mr. Trump wrote to Mr. Epstein in 2003, five years before the financier pleaded guilty to soliciting prostitution from a minor. The note was accompanied by a sexually suggestive drawing. Mr. Trump has denied he was responsible for the letter or the drawing. According to Monday's filing, the parties have agreed that, should the motion to dismiss be denied, Mr. Murdoch would be deposed within 30 days at a 'mutually agreed upon location in the United States.' The filing added that Mr. Murdoch had agreed to provide Mr. Trump with regular updates on his health. Mr. Murdoch, the founder of News Corp, which owns The Journal, was named in the lawsuit, as well as News Corp; Dow Jones; Robert Thomson, the chief executive of News Corp; and the two reporters who wrote the article. A representative for Mr. Murdoch did not immediately respond to a request for comment.
